6Q2A
Trypanosoma brucei CLK1 kinase domain in complex with a covalent aminobenzimidazole inhibitor AB1
Summary for 6Q2A
Entry DOI | 10.2210/pdb6q2a/pdb |
Descriptor | Protein kinase, putative, SULFATE ION, ~{N}-[1-[(3~{R})-1-[4-(dimethylamino)but-2-enoyl]azepan-3-yl]-7-methyl-benzimidazol-2-yl]-2-methyl-pyridine-4-carboxamide, ... (4 entities in total) |
Functional Keywords | kinase, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
Biological source | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) |
Total number of polymer chains | 16 |
Total formula weight | 668678.53 |
Authors | Ma, X.,Ornelas, E. (deposition date: 2019-08-07, release date: 2020-06-17, Last modification date: 2023-10-11) |
Primary citation | Saldivia, M.,Fang, E.,Ma, X.,Myburgh, E.,Carnielli, J.B.T.,Bower-Lepts, C.,Brown, E.,Ritchie, R.,Lakshminarayana, S.B.,Chen, Y.L.,Patra, D.,Ornelas, E.,Koh, H.X.Y.,Williams, S.L.,Supek, F.,Paape, D.,McCulloch, R.,Kaiser, M.,Barrett, M.P.,Jiricek, J.,Diagana, T.T.,Mottram, J.C.,Rao, S.P.S. Targeting the trypanosome kinetochore with CLK1 protein kinase inhibitors. Nat Microbiol, 5:1207-1216, 2020 Cited by PubMed: 32661312DOI: 10.1038/s41564-020-0745-6 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.6 Å) |
Structure validation
Download full validation report